Free Trial

Rockwell Medical Q2 2024 Earnings Report

Rockwell Medical logo
$1.77 -0.03 (-1.67%)
As of 02/21/2025 04:00 PM Eastern

Rockwell Medical EPS Results

Actual EPS
$0.01
Consensus EPS
-$0.04
Beat/Miss
Beat by +$0.05
One Year Ago EPS
-$0.18

Rockwell Medical Revenue Results

Actual Revenue
$25.83 million
Expected Revenue
$23.01 million
Beat/Miss
Beat by +$2.82 million
YoY Revenue Growth
N/A

Rockwell Medical Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

RMTI Upcoming Earnings

Rockwell Medical will be holding an earnings conference call on Thursday, March 20 at 8:00 AM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Conference Call Audio

Rockwell Medical Earnings Headlines

Your trading day could end at 11 AM
What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?
See More Rockwell Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rockwell Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rockwell Medical and other key companies, straight to your email.

About Rockwell Medical

Rockwell Medical (NASDAQ:RMTI), together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

View Rockwell Medical Profile

More Earnings Resources from MarketBeat